Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics.
Tombal B, Miller K, Boccon-Gibod L, Schröder F, Shore N, Crawford ED, Moul J, Jensen JK, Kold Olesen T, Persson BE. Tombal B, et al. Among authors: jensen jk. Eur Urol. 2010 May;57(5):836-42. doi: 10.1016/j.eururo.2009.11.029. Epub 2009 Nov 20. Eur Urol. 2010. PMID: 19962227 Clinical Trial.
A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer.
Crawford ED, Tombal B, Miller K, Boccon-Gibod L, Schröder F, Shore N, Moul JW, Jensen JK, Olesen TK, Persson BE. Crawford ED, et al. Among authors: jensen jk. J Urol. 2011 Sep;186(3):889-97. doi: 10.1016/j.juro.2011.04.083. Epub 2011 Jul 23. J Urol. 2011. PMID: 21788033 Clinical Trial.
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses.
Ulmert D, Vickers AJ, Scher HI, Becker C, Iversen P, Frankel D, Jensen JK, Olesen TK, Lilja H. Ulmert D, et al. Among authors: jensen jk. Clin Chem Lab Med. 2012 Nov;50(11):1993-8. doi: 10.1515/cclm-2011-0967. Clin Chem Lab Med. 2012. PMID: 22718641 Free PMC article. Clinical Trial.
Effect of Alirocumab on Carotid Inflammation by [18F]FDG PET in Patients With Acute Myocardial Infarction.
Bang LE, Jensen JK, Räber L, Koskinas KC, Bär S, Losdat S, Matter CM, Lonborg J, Radu Juul Jensen MD, Kjaer A, Engstrøm T, Ripa RS. Bang LE, et al. Among authors: jensen jk. JACC Cardiovasc Imaging. 2024 Apr 10:S1936-878X(24)00131-1. doi: 10.1016/j.jcmg.2024.04.001. Online ahead of print. JACC Cardiovasc Imaging. 2024. PMID: 38678449 No abstract available.
261 results